在典型发育 (TD) 儿童的失眠管理中使用黑色素:技术报告
, Judith Owens1, Narong Simakajornboon2
1Department of Neurology, Pediatric Sleep Center, Boston Children's Hospital, Boston, MA, USA.
Sleep medicine
|February 1, 2025
概括
黑素经常用于儿科失眠,但缺乏指导方针. 本综述为医疗保健从业人员提供了基于证据的建议,建议在典型发育的儿童中使用它.
科学领域:
- 儿科睡眠医学 儿科睡眠医学
- 药理学 药理学是指药理学的学科.
- 临床实践指南 临床实践指南
背景情况:
- 黑素在全球范围内用于儿童失眠管理.
- 对儿童,特别是典型发育期 (TD) 儿童的黑激素使用的临床指南很少.
- 现有的有关TD儿童的黑激素疗效和安全性的数据是有限的或不确定的.
研究的目的:
- 检查有关儿科失眠的黑激素的现有文献.
- 为从业者制定基于证据和基于共识的建议.
- 为指导临床决策,关于在TD儿童中使用黑色素.
主要方法:
- 关于在儿科睡眠中使用黑激素的文献综述.
- 国际儿科睡眠协会 (IPSA) 成立了一个工作组.
- 根据现有证据和专家共识制定建议.
主要成果:
- 关于儿科临床环境中黑激素的使用,疗效和安全性的证据摘要.
- 专注于典型发育 (TD) 的儿童.
- 特定临床建议的附带文件.
结论:
- 国际儿科睡眠协会 (IPSA) 已经制定了有关黑激素使用的建议.
- 这些指南旨在支持从业人员管理儿科失眠.
- 该摘要为该领域的基于证据的实践提供了基础.
相关概念视频
Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
Sedatives and Hypnotics Drugs: Miscellaneous Agents
144
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
144
Insomnia
78
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
78
Nightmares and Night Terrors
73
Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
Nightmares...
73
Insufficient Sleep and Sleep Deprivation
130
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
130
Narcolepsy
89
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
89


